New pages
From IDWiki
13 December 2025
- 15:3515:35, 13 December 2025 Benign acute childhood myositis (hist | edit) [314 bytes] Aidan (talk | contribs) (Created page with "* Self-limited illness * Most commonly caused by influenza B, followed by influenza A; can be caused by parainfluenza, EBV, CMV, HHV-6, RSV, coxsackievirus, Mycoplasma pneumoniae, Streptococcus pyogenes, Legionella, and Salmonella * Treatment is primarily supportive") Tag: Visual edit
18 November 2025
- 13:4913:49, 18 November 2025 CR:DOI:9df2817948e9be7a8265c5cabb8e1cf4 (hist | edit) [521 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=knafl2020sc |type=journal-article |title=Schistosomiasis-associated pulmonary arterial hypertension: a systematic review |author=Daniela Knafl;Christian Gerges;Charles H. King;Marc Humbert;Amaya L. Bustinduy|+sep=; |journal=European Respiratory Review |publisher=European Respiratory Society (ERS) |year=2020 |volume=29 |issue=155 |pages=190089 |doi=10.1183/16000617.0089-2019 |issn=0905-9180;1600-0617|+sep=; |retrieved-from=https://dx.doi....")
14 November 2025
- 19:4919:49, 14 November 2025 CR:DOI:159a1e833ccfa1d20c036f367538d644 (hist | edit) [496 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=scott2013a |type=journal-article |title=A Systematic Approach to the Diagnosis of Suspected Central Nervous System Lymphoma |author=Brian J. Scott;Vanja C. Douglas;Tarik Tihan;James L. Rubenstein;S. Andrew Josephson|+sep=; |journal=JAMA Neurology |publisher=American Medical Association (AMA) |year=2013 |volume=70 |issue=3 |pages=311 |doi=10.1001/jamaneurol.2013.606 |issn=2168-6149 |retrieved-from=https://dx.doi.org/ |retrieved-on=2025-...")
- 19:4919:49, 14 November 2025 Primary CNS lymphoma (hist | edit) [367 bytes] Aidan (talk | contribs) (Created page with "==Investigations== * CSF ** Abnormal in 80% of CNS lymphomas ** Normal cell counts in 30-60% of cases ** Protein normal in 30-55% of cases ** Can result in hypoglycorrhachia (median of 4.1 mmol/L but below 0.8 mmol/L in up to 20% of patients) ** Cytology can be diagnostic Category:HematologyCategory:OncologyCategory:Neurology")
- 14:4614:46, 14 November 2025 Imipenem-cilastatin (hist | edit) [446 bytes] Aidan (talk | contribs) (Created page with "== Background == * Broad-spectrum carbapenem * Spectrum includes enterococci and Acinetobacter ** Compared to meropenem, imipenem is more active against Acinetobacter and enterococci, and less active against Pseudomonas == Dosing == * Routine: 500 mg IV every 6 hours * Cystitis: 250-500 mg IV every 6 hours * Severe or pseudomonal infections: consider up to 1 g IV every 6 to 8 hours Category:Carbapenems") Tag: Visual edit
- 14:4014:40, 14 November 2025 CR:DOI:04c596f2c73ee58b3f1bc7a2287ce3f8 (hist | edit) [610 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=fraenkel2006in |type=journal-article |title=In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals |author=Carl-Johan Fraenkel;Måns Ullberg;Sverker Bernander;Evalena Ericson;Peter Larsson;Johan Rydberg;Eva Törnqvist;Åsa Melhus|+sep=; |journal=Scandinavian Journal of Infectious Diseases |publisher=Informa UK Limited |year=2006 |volume=38 |issue=10 |pages=853-859 |doi=10....")
11 November 2025
- 15:5415:54, 11 November 2025 Meninges (hist | edit) [458 bytes] Aidan (talk | contribs) (Created page with "* Layers of tissue surrounding an protecting the brain * Three meninges: dura mater (outermost), arachnoid mater (middle), and pia mater (innermost) ** Grouped into pachymeninges (dura mater) and leptomeninges (arachnoid mater and pia mater) * Several potential spaces exist: epidural space (outside the dura mater), subdural space (between dura mater and arachnoid mater), and subarachnoid space (between arachnoid mater and pia mater) Category:Anatomy") Tag: Visual edit
- 14:4614:46, 11 November 2025 CR:PMID:6371440 (hist | edit) [3,168 bytes] Aidan (talk | contribs) (Created page with "{{#scite:PMID6371440 |type=Journal Article;Review|+sep=; |title=Pasteurella multocida infections. Report of 34 cases and review of the literature. |author=Weber DJ;Wolfson JS;Swartz MN;Hooper DC|+sep=; |journal=Medicine |iso-abbreviation=Medicine (Baltimore) |pubdate=1984 May |year=1984 |volume=63 |issue=3 |pages=133-54 |abstract=Pasteurella multocida, a small, gram-negative coccobacillus , is part of the normal oral flora of many animals, including the dog an...")
- 14:4414:44, 11 November 2025 CR:DOI:e3caec96a3a0431e7d12b62e06bdd61c (hist | edit) [512 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=wei2025pa |type=journal-article |title=Pasteurella multocida infection: a differential retrospective study of 482 cases of P. multocida infection in patient of different ages |author=Bo Wei;Chang Liu;Jie Zhu;XinYu Zou;Zhenhua Zhang|+sep=; |journal=BMC Infectious Diseases |publisher=Springer Science and Business Media LLC |year=2025 |volume=25 |issue=1 |doi=10.1186/s12879-025-10711-1 |issn=1471-2334 |retrieved-from=https://dx.doi.org/ |re...")
21 October 2025
- 13:4213:42, 21 October 2025 CR:DOI:e05c1b1bd95a37178e2f082567f7fc3d (hist | edit) [561 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=foong2019ri |type=journal-article |title=Risk factors predicting Candida infective endocarditis in patients with candidemia |author=Kap Sum Foong;Abby Sung;Jason P Burnham;Ryan Kronen;Qinghua Lian;Ana Salazar Zetina;Kevin Hsueh;Charlotte Lin;William G Powderly;Andrej Spec|+sep=; |journal=Medical Mycology |publisher=Oxford University Press (OUP) |year=2019 |volume=58 |issue=5 |pages=593-599 |doi=10.1093/mmy/myz104 |issn=1369-3786;1460-2709...")
20 October 2025
- 18:1018:10, 20 October 2025 CR:DOI:20f798b13f3d1ba4bd6cc25dbc3aafea (hist | edit) [516 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=bourbeau2016is |type=journal-article |title=Is the Presence of Actinomyces spp. in Blood Culture Always Significant? |author=Anna Jeffery-Smith;Caoimhe Nic-Fhogartaigh;Michael Millar|+sep=; |editor=P. Bourbeau |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2016 |volume=54 |issue=4 |pages=1137-1139 |doi=10.1128/jcm.03074-15 |issn=0095-1137;1098-660X|+sep=; |retrieved-from=https://dx.doi.org/...")
- 18:0818:08, 20 October 2025 PERMA model (hist | edit) [350 bytes] Aidan (talk | contribs) (Created page with "* Model of wellbeing * Includes the following components: ** Positive emotion: the experience of joy, pleasure, etc. ** Engagement: being in "flow state" with an activity ** Relationships: having strong, meaningful relationships ** Meaning: purpose and belonging in ** Accomplishment: pursuit of goals and feeling of mastery Category:Psychiatry") Tag: Visual edit
13 October 2025
- 19:5719:57, 13 October 2025 Corticobasal degeneration (hist | edit) [2,542 bytes] Aidan (talk | contribs) (Created page with "== Background == * One of the Parkinson-plus syndromes == Clinical Manifestations == * Rigidity, bradykinesia or clumsy limb, postural instability, falls, abnormal gait, axial rigidity, tremor (including myoclonus that is mistaken tremor), limb dystonia, and myoclonus * Cognitive impairment, behavioural changes, limb apraxia, aphasia, depression, cortical sensory loss, and alien limb == Diagnostic Criteria == * From CiteRef::armstrong20...") Tag: Visual edit
- 19:4619:46, 13 October 2025 CR:DOI:87e3919afc66cd0429b4e43c4b577e82 (hist | edit) [735 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=armstrong2013cr |type=journal-article |title=Criteria for the diagnosis of corticobasal degeneration |author=Melissa J. Armstrong;Irene Litvan;Anthony E. Lang;Thomas H. Bak;Kailash P. Bhatia;Barbara Borroni;Adam L. Boxer;Dennis W. Dickson;Murray Grossman;Mark Hallett;Keith A. Josephs;Andrew Kertesz;Suzee E. Lee;Bruce L. Miller;Stephen G. Reich;David E. Riley;Eduardo Tolosa;Alexander I. Tröster;Marie Vidailhet;William J. Weiner|+sep=; |journal=N...")
12 October 2025
- 19:2519:25, 12 October 2025 CHA2DS2-VASc (hist | edit) [1,075 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:CHA<sub>2</sub>DS<sub>2</sub>-VASc}} == Background == * Risk stratification tool used to help determine utility of anticoagulation in atrial fibrillation == Criteria == {| class="wikitable" ! colspan="2" |Criteria !Points |- | rowspan="3" |Age |<65 |0 |- |65-74 |1 |- |≥75 |2 |- | colspan="2" |Female sex |1 |- | colspan="2" |CHF history |1 |- | colspan="2" |Hypertension |1 |- | colspan="2" |Stroke/TIA/thomboembolism |2 |- | colspan="2" |Vascular di...") Tag: Visual edit
- 17:5317:53, 12 October 2025 Dystonia (hist | edit) [1,202 bytes] Aidan (talk | contribs) (Created page with "== Background == * A movement disorder characterized by intermittent or sustained abnormal movements or postures === Etiologies === * Inherited or genetic: many, many causes * Idiopathic * Secondary or acquired ** Perinatal brain injury ** Stroke from ischemia, hemorrhage, or AVM ** Acquired brain injury from trauma, surgery, or electrocution ** Medications *** Antihistamines *** Antimalarials including chloroquine *** Antiseizure medications *** CCBs *** Choliner...") Tag: Visual edit
6 October 2025
- 17:4617:46, 6 October 2025 X-linked agammaglobulinemia (hist | edit) [1,322 bytes] Aidan (talk | contribs) (Created page with "== Background == * A primary immunodeficiency that causes agammaglobulinemia * X-linked recessive, so almost all cases are men ** An autosomal recessive form exists called autosomal recessive agammaglobulinemia * One of the most common pediatric primary immunodeficiencies, though delayed presentations are possible ** Average age of diagnosis is 2.5 years, with majority of cases diagnosed by 5 years === Pathophysiology === * Mutation of Bruton's tyrosine kinase...") Tag: Visual edit
- 14:4214:42, 6 October 2025 Pemphigus vulgaris (hist | edit) [909 bytes] Aidan (talk | contribs) (Created page with "== Background == * Blistering skin condition of unknown etiology * Associated with autoantibodies targeting cadherins === Drug-Induced === * Penicillamine and captopril * NSAIDs, penicillin, and cephalosporins * Possibly certain foods, though mostly anecdotal == Clinical Manifestations == * Initially presents in oral mucosa in 80% of cases * Followed by cutaneous lesions * Lesions are bullae that rupture leaving painful erosions * '''Nikolsky sign''' may be...") Tag: Visual edit
3 October 2025
- 19:5219:52, 3 October 2025 CR:DOI:0c5083d354004ce136f5a154d1a82809 (hist | edit) [447 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=janda2016pl |type=journal-article |title=Plesiomonas shigelloides Revisited |author=J. Michael Janda;Sharon L. Abbott;Christopher J. McIver|+sep=; |journal=Clinical Microbiology Reviews |publisher=American Society for Microbiology |year=2016 |volume=29 |issue=2 |pages=349-374 |doi=10.1128/cmr.00103-15 |issn=0893-8512;1098-6618|+sep=; |retrieved-from=https://dx.doi.org/ |retrieved-on=2025-10-03 |@show=true }}")
- 15:5815:58, 3 October 2025 Solobacterium moorei (hist | edit) [768 bytes] Aidan (talk | contribs) (Created page with "== Background == * Non-spore-forming strictly anaerobic Stain::Gram-positive Shape::bacillus * Typically isolated from human feces and difficult to cluster == Clinical Manifestations == * Associated with halitosis and odontogenic infections * Rare bacteremia, particularly in immunocompromised peopleCiteRef::detry2006seCiteRef::pedersen2011so * Rare wound infections == Management == * Appears to be generally susceptible to most antibiotics, including...") Tag: Visual edit
- 15:5815:58, 3 October 2025 CR:DOI:38c0b6c9e2d1528222521e987cd84f7e (hist | edit) [530 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=pedersen2011so |type=journal-article |title=Solobacterium moorei Bacteremia: Identification, Antimicrobial Susceptibility, and Clinical Characteristics |author=Rune Micha Pedersen;Hanne Marie Holt;Ulrik Stenz Justesen|+sep=; |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2011 |volume=49 |issue=7 |pages=2766-2768 |doi=10.1128/jcm.02525-10 |issn=0095-1137;1098-660X|+sep=; |retrieved-from=https:...")
- 15:5815:58, 3 October 2025 CR:DOI:804c4fe07b0de921b874dc6256d3ef72 (hist | edit) [592 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=zheng2010ph |type=journal-article |title=Phenotypic and Molecular Characterization of Solobacterium moorei Isolates from Patients with Wound Infection |author=Guili Zheng;Paula H. Summanen;David Talan;Robert Bennion;Marie-Claire Rowlinson;Sydney M. Finegold|+sep=; |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2010 |volume=48 |issue=3 |pages=873-876 |doi=10.1128/jcm.0138...")
- 15:5715:57, 3 October 2025 CR:DOI:b5baff6ee77428ce0cca0b97b362d58c (hist | edit) [453 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=detry2006se |type=journal-article |title=Septicemia due to Solobacterium moorei in a patient with multiple myeloma |author=G. Detry;D. Pierard;K. Vandoorslaer;G. Wauters;V. Avesani;Y. Glupczynski|+sep=; |journal=Anaerobe |publisher=Elsevier BV |year=2006 |volume=12 |issue=3 |pages=160-162 |doi=10.1016/j.anaerobe.2006.04.002 |issn=1075-9964 |retrieved-from=https://dx.doi.org/ |retrieved-on=2025-10-03 |@show=true }}")
2 October 2025
- 16:1216:12, 2 October 2025 Mycobacterium bovis (BCG strain) (hist | edit) [1,537 bytes] Aidan (talk | contribs) (Created page with "== Background == * Intravesicular instillation is used to treat bladder cancer == Clinical Manifestations == * Median time from instillation to onset of symptoms is Incubation period::169 daysCiteRef::cabas2021bc (range 3 months to many years) * Disease can disseminate to liver, lungs, bone marrow, bones, joints (in descending order of frequency) * Localized disease can cause cystitis, bladder contractures, granulomatous prostatitis, prostate abscess, epid...") Tag: Visual edit originally created as "BCG infection"
- 16:0416:04, 2 October 2025 CR:DOI:7b11983fdb4b47719c755d94414b8105 (hist | edit) [634 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=cabas2021bc |type=journal-article |title=BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review |author=Paolo Cabas;Michele Rizzo;Mauro Giuffrè;Roberta Maria Antonello;Carlo Trombetta;Roberto Luzzati;Giovanni Liguori;Stefano Di Bella|+sep=; |journal=Urologic Oncology: Seminars and Original Investigations |publisher=Elsevier BV |year=2021 |volume...")
- 15:3215:32, 2 October 2025 Enfortumab vedotin (hist | edit) [604 bytes] Aidan (talk | contribs) (Created page with "* Antibody-drug conjugate targeting Nectin-4 that is present on the surface of most urothelial cancer cells * Indicated for urothelial cancer * Common adverse effects include: rashes (about 50%, can be severe), alopecia (in about 50%); abdominal pain, anorexia, constipation, diarrhea, and nausea/vomiting; fatigue; myelosuppression; myalgias; dysgeusia; peripheral neuropathy (in about 50%, can be severe); dry eyes ** Also liver enzyme abnormalities, insomnia, hypergly...") Tag: Visual edit
- 15:0215:02, 2 October 2025 CR:DOI:d14017def84fc22da503fdd490bb0b3a (hist | edit) [550 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=miller2023co |type=journal-article |title=Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study |author=Aaron C Miller;Alan T Arakkal;Daniel K Sewell;Alberto M Segre;Joseph Tholany;Philip M Polgreen;|+sep=; |journal=Open Forum Infectious Diseases |publisher=Oxford University Press (OUP) |year=2023 |volume=10 |issue=8 |doi=10.1093/ofid/ofad413 |issn=2328-8957 |r...")
- 15:0015:00, 2 October 2025 CR:DOI:484c0725a5f4bd4d826b3f1321b5686d (hist | edit) [567 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=liu2024ri |type=journal-article |title=Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data |author=Yangxi Liu;Mengfei Dai;Kanghuai Zhang;Li Zhang;Bin Lin;Keyu Chen;Haitao Wang;Zhichun Gu;Yuetian Yu;Yan Wang|+sep=; |journal=International Journal of Antimicrobial Agents |publisher=Elsevier BV |year=2024 |volume=64 |issue=4 |pages=107288 |doi=10.1016/j.ijantimicag.2024.107288 |i...")
- 14:5814:58, 2 October 2025 CR:DOI:1ec3e49d4680d8d915977fc8bb2ee8c4 (hist | edit) [561 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=gilboa2025an |type=journal-article |title=Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection |author=Mayan Gilboa;Gili Regev-Yochay;Eyal Meltzer;Ido Cohen;Yovel Peretz;Tal Zilberman-Daniels;Amitai Segev;Sharon Amit;Dafna Yahav;Noam Barda|+sep=; |journal=JAMA Network Open |publisher=American Medical Association (AMA) |year=2025 |volume=8 |issue=8 |pages=e2525252 |doi=10.1001/jamanetworkopen.2025.25252 |issn=25...")
- 14:3614:36, 2 October 2025 CR:DOI:415d00cc0f165bd9079d5acf07764747 (hist | edit) [518 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=phillips2022im |type=journal-article |title=Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study |author=Emma C. Phillips;Cirle A. Warren;Jennie Z. Ma;Gregory R. Madden|+sep=; |journal=Antimicrobial Agents and Chemotherapy |publisher=American Society for Microbiology |year=2022 |volume=66 |issue=6 |doi=10.1128/aac.00001-22 |issn=0066-4804;1098-6596|+sep=; |retrieved-from=https://dx.doi.org...")
- 14:2914:29, 2 October 2025 CR:DOI:877d53e0da2abb06283993a9959f1ac8 (hist | edit) [436 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=heleno2021fi |type=journal-article |title=Fidaxomicin as a Salvage Therapy for Fulminant Clostridioides difficile Infection |author=Caio T Heleno;Aleksey Tagintsev;Katharine Lasley;Douglas Summerfield|+sep=; |journal=Cureus |publisher=Springer Science and Business Media LLC |year=2021 |doi=10.7759/cureus.16559 |issn=2168-8184 |retrieved-from=https://dx.doi.org/ |retrieved-on=2025-10-02 |@show=true }}")
29 September 2025
- 20:4620:46, 29 September 2025 Drug-induced thrombocytopenia (hist | edit) [905 bytes] Aidan (talk | contribs) (Created page with "* Typical onset 5 to 10 days after drug administration ** Nadir of less than 20 ** A severe form is heparin-induced thrombocytopenia, discussed elsewhere ** Counts usually start to recover after 4 or 5 half-lives of the offending medication * IVIG can be given in severe thrombocytopenia * Drugs associated with non-immune thrombocytopenia ** Impaired thrombopoiesis: chemotherapy, interferon-alpha, linezolid, botrezomib, thiazide diuretics, ethanol, tolbutamid, g...") Tag: Visual edit
- 18:3518:35, 29 September 2025 Golimumab (hist | edit) [474 bytes] Aidan (talk | contribs) (Created page with "* Humanized monoclonal antibody targeting TNF * Indications including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis Category:Monoclonal antibodies") Tag: Visual edit
19 September 2025
- 14:1114:11, 19 September 2025 Central venous access device-related upper extremity deep vein thrombosis (hist | edit) [753 bytes] Aidan (talk | contribs) (Created page with " == Management == * Anticoagulation * If CVAD still needed: continue anticoagulation while it is in situ * If CVAD no longer needed: ** If it can be left in situ, leave it for up to 3-5 days, up to 7 days, while on anticoagulation to reduce risk of embolism ** Continue anticoagulation for 3 months * Choice of anticoagulation is primarily LMWH == Prevention == * Use small calibre catheter possible * Ensure proper catheter tip location * Remove CVADs when no longer...") Tag: Visual edit
- 03:5403:54, 19 September 2025 CR:DOI:93a20281efae8df25b04c217a2b9e759 (hist | edit) [472 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=hermans2024po |type=journal-article |title=Post-tuberculosis treatment paradoxical reactions |author=Sabine M. Hermans;Onno W. Akkerman;Graeme Meintjes;Martin P. Grobusch|+sep=; |journal=Infection |publisher=Springer Science and Business Media LLC |year=2024 |volume=52 |issue=5 |pages=2083-2095 |doi=10.1007/s15010-024-02310-0 |issn=0300-8126;1439-0973|+sep=; |retrieved-from=https://dx.doi.org/ |retrieved-on=2025-09-19 |@show=true }}")
- 03:5103:51, 19 September 2025 CR:DOI:3917348f8490a2874a73be4769774c60 (hist | edit) [579 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=hawkey2005ch |type=journal-article |title=Characterization and Management of Paradoxical Upgrading Reactions in HIV-Uninfected Patients with Lymph Node Tuberculosis |author=C. R. Hawkey;T. Yap;J. Pereira;D. A. J. Moore;R. N. Davidson;G. Pasvol;O. M. Kon;R. A. Wall;R. J. Wilkinson|+sep=; |journal=Clinical Infectious Diseases |publisher=Oxford University Press (OUP) |year=2005 |volume=40 |issue=9 |pages=1368-1371 |doi=10.1086/429317 |issn=1...")
- 03:4903:49, 19 September 2025 CR:DOI:5d6fdd1fb4d601ac3b859435236fe3d1 (hist | edit) [516 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=van loenhout-rooyackers2000sh |type=journal-article |title=Shortening the duration of treatment for cervical tuberculous lymphadenitis |author=JH van Loenhout-Rooyackers;RJ Laheij;C Richter;AL Verbeek|+sep=; |journal=European Respiratory Journal |publisher=European Respiratory Society (ERS) |year=2000 |volume=15 |issue=1 |pages=192-195 |doi=10.1183/09031936.00.15119200 |issn=0903-1936;1399-3003|+sep=; |retrieved-from=https://dx.doi.org/...")
- 03:2903:29, 19 September 2025 CR:DOI:13a597f6f29e1c215a69fc2351732611 (hist | edit) [550 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=vega2024ri |type=journal-article |title=Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis |author=Victor Vega;Javier Cabrera-Sanchez;Sharon Rodríguez;Kristien Verdonck;Carlos Seas;Larissa Otero;Patrick Van der Stuyft|+sep=; |journal=BMJ Open Respiratory Research |publisher=BMJ |year=2024 |volume=11 |issue=1 |pages=e002281 |doi=10.1136/bmjresp-2023-002281 |issn=2052-4439 |r...")
- 03:2503:25, 19 September 2025 Recurrent tuberculosis (hist | edit) [648 bytes] Aidan (talk | contribs) (Created page with "* Recurrence of TB infection, either as relapse of initial infection (around 80% of recurrences in low-endemic settingsCiteRef::vega2021re) or reinfection (more common in regions with endemic TB) * Occurs at a rate of about 2.26 per 100 person years at riskCiteRef::vega2021re * Typically occurs during first 2 years ** Relapses in susceptible TB mostly occur during first 6 months (78%) and almost always during first 12 months (91%) of therapy[[CiteRef::nunn2010ti]...") Tag: Visual edit
- 03:2503:25, 19 September 2025 CR:PMID:20074418 (hist | edit) [553 bytes] Aidan (talk | contribs) (Created page with "{{#scite:PMID20074418 |type=Journal Article |title=Timing of relapse in short-course chemotherapy trials for tuberculosis. |author=Nunn AJ;Phillips PP;Mitchison DA|+sep=; |journal=The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease |iso-abbreviation=Int J Tuberc Lung Dis |pubdate=2010 Feb |year=2010 |volume=14 |issue=2 |pages=241-2 |abstract=We have reviewed the resu...")
- 03:2003:20, 19 September 2025 CR:DOI:2c78080545901114e8b6601446040655 (hist | edit) [514 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=vega2021re |type=journal-article |title=Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections |author=Victor Vega;Sharon Rodríguez;Patrick Van der Stuyft;Carlos Seas;Larissa Otero|+sep=; |journal=Thorax |publisher=BMJ |year=2021 |volume=76 |issue=5 |pages=494-502 |doi=10.1136/thoraxjnl-2020-215449 |issn=0040-6376;1468-3296|+sep=; |retrieved-from=https://dx.doi.org/ |...")
18 September 2025
- 16:4716:47, 18 September 2025 WIfI system (hist | edit) [6,417 bytes] Aidan (talk | contribs) (Created page with "== Background == * Developed by the Society for Vascular Surgery to stage at-risk limbs in patients with chronic limb-threatening ischemia, including patients with and without diabetes == Criteria == === Wound === {| class="wikitable" !Grade !DFU !Gangrene !Description |- |0 |No ulcer |No gangrene |Minor tissue loss. Salvageable with simple digital amputation or skin coverage. |- |1 |Small, shallow ulcer on distal leg or foot; no exposed bone, unless limited to distal...") Tag: Visual edit
- 16:0516:05, 18 September 2025 Diabetic foot ulcer (hist | edit) [906 bytes] Aidan (talk | contribs) (Created page with "== Background == * Foot ulcer in a patient with diabetes mellitus * Pathophysiology is from minor trauma in the context of: ** Neuropathy: sensory, motor, and autonomic ** Arteriopathy ** Immune dysfunction == SINBAD system == * Simple scoring system used for triaging diabetic foot ulcer {| class="wikitable" !Criterion !Value !Score |- | rowspan="2" |Site |Forefoot |0 |- |Midfoot or hindfoot |1 |- | rowspan="2" |Ischemia |Pedal blood flow intact, with at least on...") Tag: Visual edit
- 15:5315:53, 18 September 2025 Headache with neurological deficits and cerebrospinal fluid lymphocytosis (hist | edit) [372 bytes] Aidan (talk | contribs) (Created page with "* Benign, generally self-limited syndrome * Unknown etiology * Characterized by moderate-to-severe migraine-like headaches with associated temporary neurological deficits (most commonly hemiparesis, hemisensory disturbances, and aphasia) ** Headaches usually bilateral and throbbing, and last around 24 hours ** Deficits usually last around 5 hours Category:Neurology") Tag: Visual edit
- 15:5015:50, 18 September 2025 Drug-induced aseptic meningitis (hist | edit) [1,049 bytes] Aidan (talk | contribs) (Created page with "== Background == === Etiologies === * NSAIDs: '''ibuprofen''' (most common), diclofenac, naproxen, sulindac * Antibiotics: cotrimoxazole, cephalosporins, amoxicillin, ciprofloxacin * Antiepileptics: lamotrigine, carbamazepine * Chemotherapy: cetuximab, intrathecal chemotherapy * Immunosuppression: methotraxate, azathioprine, TNF-alpha inhibitors (adalimumab, infliximab, etanercept) * Other: [...") Tag: Visual edit
11 September 2025
- 14:5714:57, 11 September 2025 CR:DOI:166fe0f64e8fdd4b6ae50910a9996d1a (hist | edit) [530 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=diekema2014ro |type=journal-article |title=Rothia Bacteremia: a 10-Year Experience at Mayo Clinic, Rochester, Minnesota |author=Poornima Ramanan;Jason N. Barreto;Douglas R. Osmon;Pritish K. Tosh|+sep=; |editor=D. J. Diekema |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2014 |volume=52 |issue=9 |pages=3184-3189 |doi=10.1128/jcm.01270-14 |issn=0095-1137;1098-660X|+sep=; |retrieved-from=https:...")
9 September 2025
- 17:5117:51, 9 September 2025 Avacopan (hist | edit) [172 bytes] Aidan (talk | contribs) (Created page with "* Complement 5a receptor antagonist * Indicated for granulomatosis with polyangiitis and microscopic polyangiitis Category:RheumatologyCategory:Medications")
- 15:0315:03, 9 September 2025 CR:DOI:cec85d75d06e8681143a9c823fe4b66f (hist | edit) [584 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=milosavljevic2021an |type=journal-article |title=Antimicrobial treatment of Corynebacterium striatum invasive infections: a systematic review |author=Milos N. Milosavljevic;Jovana Z. Milosavljevic;Aleksandar G. Kocovic;Srdjan M. Stefanovic;Slobodan M. Jankovic;Miralem Djesevic;Milica N. Milentijevic|+sep=; |journal=Revista do Instituto de Medicina Tropical de São Paulo |publisher=FapUNIFESP (SciELO) |year=2021 |volume=63 |doi=10.1590/s1678-...")
8 September 2025
- 18:1318:13, 8 September 2025 Eosinophilic cellulitis (hist | edit) [1,235 bytes] Aidan (talk | contribs) (Created page with "== Background == * Idiopathic syndrome of eosinophilic infiltration into skin * Many proposed triggers but none definite == Clinical Manifestations == * Sudden onset large, inflamed edematous patches, often with vesicles or bullae mimicking cellulitis * Often preceded by pruritus or burning * Often on trunk and extremities * Fevers may be absent or low-grade * Patches evolve over days, and can have central healing while border becomes purple * Patches regress with...") Tag: Visual edit
4 September 2025
- 00:5300:53, 4 September 2025 Streptococcus gordonii (hist | edit) [463 bytes] Aidan (talk | contribs) (Created page with "== Background == {{DISPLAYTITLE:''Streptococcus gordonii''}} * Species of Stain::Gram-positive Shape::coccus within the genus Genus::Streptococcus * Commensal member of skin, oral, and intestinal flora == Clinical Manifestations == * Apical periodontitis * Infective endocarditis (about 40-50% of patients with bacteremia will have endocarditis) * Also: empyema, vertebral osteomyelitis/discitis, liver abscess Category:Gram-positive cocci") Tag: Visual edit